Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma

Overview of attention for article published in Expert Opinion on Emerging Drugs, March 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 21,377 followers.

RT @sonpavde: Monoclonal antibodies (non-ICI) for metastatic #urothelialcarcinoma #bladdercancer-we review previously investigated targets…

RT @sonpavde: Monoclonal antibodies (non-ICI) for metastatic #urothelialcarcinoma #bladdercancer-we review previously investigated targets…

RT @sonpavde: Monoclonal antibodies (non-ICI) for metastatic #urothelialcarcinoma #bladdercancer-we review previously investigated targets…

RT @sonpavde: Monoclonal antibodies (non-ICI) for metastatic #urothelialcarcinoma #bladdercancer-we review previously investigated targets…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.